ArticleCancers2024

Real-World Prevalence and Tolerability of Immune-Related Adverse Events in Older Adults with Non-Small Cell Lung Cancer: A Multi-Institutional Retrospective Study.

Ryosuke Matsukane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.